Hartman Institute for Therapeutic Organ Regeneration

Synthesis of a boron-containing amidoxime reagent and its application to synthesize functionalized oxadiazole and quinazolinone derivatives.

TitleSynthesis of a boron-containing amidoxime reagent and its application to synthesize functionalized oxadiazole and quinazolinone derivatives.
Publication TypeJournal Article
Year of Publication2022
AuthorsDas BC, Nandwana NK, Ojha DP, Das S, Evans T
JournalTetrahedron Lett
Volume92
Date Published2022 Mar 02
ISSN0040-4039
Abstract

<p>Herein, we report the design, synthesis and application of a borylated amidoxime reagent for the direct synthesis of functionalized oxadiazole and quinazolinone derivatives. This reagent exhibits broad synthetic utility to obtain a variety of biologically relevant drug-like molecules. It can be easily prepared at large scale from relatively inexpensive reagents, and can undergo facile transformations to obtain target compounds. The developed amidoxime reagent was synthesized from 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile and hydroxyl amine hydrochloride using -diisopropylethylamine as a base in ethanol under reflux conditions. Overall advantages include a metal-free route to boronated oxadiazoles, quinazolinone derivatives, and restriction of the multistep sequences. Importantly, the boron-rich pharmacophore derived compounds were obtained through an efficient and inexpensive strategy.</p>

DOI10.1016/j.tetlet.2022.153657
Alternate JournalTetrahedron Lett
PubMed ID35935920
PubMed Central IDPMC9348647
Grant ListR01 AI132614 / AI / NIAID NIH HHS / United States
R01 NS109423 / NS / NINDS NIH HHS / United States
R21 AA027374 / AA / NIAAA NIH HHS / United States

Weill Cornell Medicine
Hartman Institute for Therapeutic Organ Regeneration
1300 York Ave, Box 136 New York, NY 10065